Veracyte to Acquire HalioDx, Positioning for Global Cancer Diagnostics Growth

Go back to Veracyte to Acquire HalioDx, Positioning for Global Cancer Diagnostics Growth
VERACYTE (NASDAQ: VCYT) Delayed: 57.48 +0.51 (0.90%)
Previous Close $56.97    52 Week High $8.45 
Open $55.93    52 Week Low $4.21 
Day High $57.70    P/E N/A 
Day Low $55.62    EPS $-1.52 
Volume 853,208